JPS5382775A - Optically active isomer* method for its production and analgesic drugs containing said stereoisomer - Google Patents

Optically active isomer* method for its production and analgesic drugs containing said stereoisomer

Info

Publication number
JPS5382775A
JPS5382775A JP13735477A JP13735477A JPS5382775A JP S5382775 A JPS5382775 A JP S5382775A JP 13735477 A JP13735477 A JP 13735477A JP 13735477 A JP13735477 A JP 13735477A JP S5382775 A JPS5382775 A JP S5382775A
Authority
JP
Japan
Prior art keywords
stereoisomer
production
optically active
active isomer
drugs containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP13735477A
Other languages
English (en)
Inventor
Konchi Furanko
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Viridis Ets
Original Assignee
Viridis Ets
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Viridis Ets filed Critical Viridis Ets
Publication of JPS5382775A publication Critical patent/JPS5382775A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/33—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/335—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/33—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/337—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrrole Compounds (AREA)
JP13735477A 1976-11-18 1977-11-17 Optically active isomer* method for its production and analgesic drugs containing said stereoisomer Pending JPS5382775A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BE2055466A BE848465A (fr) 1976-11-18 1976-11-18 Stereo-isomeres de 1-(1'-benzyl-2' pyrryl)-2-disec.butylaminoethanols a activite analgesique et preparations pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
JPS5382775A true JPS5382775A (en) 1978-07-21

Family

ID=3865356

Family Applications (1)

Application Number Title Priority Date Filing Date
JP13735477A Pending JPS5382775A (en) 1976-11-18 1977-11-17 Optically active isomer* method for its production and analgesic drugs containing said stereoisomer

Country Status (9)

Country Link
US (1) US4148907A (ja)
JP (1) JPS5382775A (ja)
BE (1) BE848465A (ja)
CA (1) CA1077950A (ja)
DE (1) DE2751571A1 (ja)
ES (1) ES464377A1 (ja)
FR (1) FR2371428A1 (ja)
GB (1) GB1575451A (ja)
IT (1) IT1087278B (ja)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010530393A (ja) * 2007-06-18 2010-09-09 シンジェンタ パーティシペーションズ アクチェンゲゼルシャフト 殺菌剤としての置換芳香族複素環式化合物
JP2011518818A (ja) * 2008-04-24 2011-06-30 エフツージー リミテッド ピロール抗真菌剤

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE848465A (fr) * 1976-11-18 1977-03-16 Stereo-isomeres de 1-(1'-benzyl-2' pyrryl)-2-disec.butylaminoethanols a activite analgesique et preparations pharmaceutiques qui les contiennent
DE3739882A1 (de) * 1987-11-25 1989-06-08 Bayer Ag Substituierte hydroxylamine
JP6681894B2 (ja) 2014-11-21 2020-04-15 エフツージー リミテッド 抗真菌剤
GB201609222D0 (en) 2016-05-25 2016-07-06 F2G Ltd Pharmaceutical formulation
US11819503B2 (en) 2019-04-23 2023-11-21 F2G Ltd Method of treating coccidioides infection

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1154744A (en) 1966-05-17 1969-06-11 Whitefin Holding Sa Disubstituted Aminoethanols
US3629435A (en) * 1969-08-08 1971-12-21 Whitefin Holding Sa Pharmaceutical compositions acting on the central nervous system containing disubstituted aminoethanols
BE790747A (fr) * 1971-10-30 1973-02-15 Whitefin Holding Sa Stereo-isomeres du 1-(1'-(0-chloro-benzyl)-pyrrol-2'-yl) -2-dibutyl sec.-amino-ethanol et procede pour leur preparation
US4053599A (en) * 1976-02-26 1977-10-11 American Hoechst Corporation Piperazionalkylpyrrolobenzoxazalkanes
BE848465A (fr) * 1976-11-18 1977-03-16 Stereo-isomeres de 1-(1'-benzyl-2' pyrryl)-2-disec.butylaminoethanols a activite analgesique et preparations pharmaceutiques qui les contiennent

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010530393A (ja) * 2007-06-18 2010-09-09 シンジェンタ パーティシペーションズ アクチェンゲゼルシャフト 殺菌剤としての置換芳香族複素環式化合物
JP2011518818A (ja) * 2008-04-24 2011-06-30 エフツージー リミテッド ピロール抗真菌剤

Also Published As

Publication number Publication date
DE2751571A1 (de) 1978-05-24
ES464377A1 (es) 1978-09-01
FR2371428A1 (fr) 1978-06-16
IT1087278B (it) 1985-06-04
FR2371428B1 (ja) 1981-02-06
US4148907A (en) 1979-04-10
GB1575451A (en) 1980-09-24
CA1077950A (en) 1980-05-20
BE848465A (fr) 1977-03-16

Similar Documents

Publication Publication Date Title
JPS52115591A (en) Method of local medication
JPS52113593A (en) Nonnperoral medicine stock injector
YU34474A (en) Device for the distribution of drugs
JPS5379873A (en) 22position substituted 1*44dihydropyridine derivative* method for its production and its use as drug
BE854150A (fr) Composition pharmaceutique analgesique
FI911369A0 (fi) Menetelmä analgeettisen poretabletin valmistamiseksi
PT67026B (en) Process for preparing analgesic compounds
PT70696A (en) Transdermal medication system for isosorbidedinitrate
PT66407B (en) Process for preparing trans-hexahydropyridin with pharmaceutical activity
IT1075724B (it) Metodo per la produzione di polibutene liquido a contenuto maggiorato di pli-n-butene
PT66663A (en) A method for reducing the dose of a biologically active substance while maintaining the biological effect
JPS5382775A (en) Optically active isomer* method for its production and analgesic drugs containing said stereoisomer
JPS5231819A (en) Carrying method of anesthetic drug
HU179665B (en) Process for producing new acth-frangment and pharmaceutical composition containing them
HU178340B (en) Process for preparing new pharmaceutical preparations containing aryloxy-alkanolamine and monoalkylsulphate
GB2079250B (en) Drug presentation device
JPS5368743A (en) Method for separation of mixture of optically active phenylglycinamide and opticall active phenylglycine
JPS52128357A (en) Antiitumor drug
CS194187B2 (en) Insecticide means and method of production the active substances
ZA76954B (en) Method and apparatus for the packing and distributing of medicines
JPS5368776A (en) Novel imidazole derivative and method for its production and medical drugs containing same
PT67402B (en) Process for the preparation of pharmaceutical compositionscomprising stable solutions of oxytetracycline
JPS5395956A (en) Novel heleprigeninacyl derivative process for preparing same and cordially active medicine containing same
CA1028357A (en) Racemization of optically active allethrolone
CA1029037A (en) Racemization of optically active allethrolone